Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H29FO4 |
Molecular Weight | 376.4617 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C
InChI
InChIKey=GAKMQHDJQHZUTJ-ULHLPKEOSA-N
InChI=1S/C22H29FO4/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-21(15,2)20(13)17(26)9-22(14,3)19(11)18(27)10-24/h4-5,7,11,13-14,16-17,19-20,24,26H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20-,21+,22+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12650700 | https://www.ncbi.nlm.nih.gov/pubmed/3743619Curator's Comment: description was created based on several sources, including
http://www.druginfosys.com/Drug.aspx?DrugCode=1121&DrugName=Fluocortolone&type=1
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12650700 | https://www.ncbi.nlm.nih.gov/pubmed/3743619
Curator's Comment: description was created based on several sources, including
http://www.druginfosys.com/Drug.aspx?DrugCode=1121&DrugName=Fluocortolone&type=1
Fluocortolone is a topical corticosteroid (class of steroid hormones formed in the adrenal gland). Is primary indicated in condition like, Ana fissure, Dermatosis haemorrhoids, proctitis. The signs and symptoms that are produced after the acute overdosage include convulsions, respiratory arrest, allergic skin reactions. Glucocorticoids, such as fluocortolone, act through nuclear hormone receptors Schaaf and Cidlowski (2002). The two members of this family are glucocorticoid receptor (GR) type I and GR type I I. Activation of these sites alters gene expression of endogenous agents that influence immune and inflammatory responses.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2034 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12650700 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. | 1991 Aug |
|
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. | 2001 Apr |
|
Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial. | 2001 Jun |
|
Adalimumab for the treatment of fistulas in patients with Crohn's disease. | 2009 Jul |
|
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. | 2010 Apr |
|
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy. | 2010 Jan |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QH02AB03
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
S01CA04
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
C05AA08
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-VATC |
QD07AC05
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-VATC |
QC05AA08
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
D07XC05
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
D07BC03
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
D07CC06
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
H02AB03
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-VATC |
QD07CC06
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-VATC |
QD07BC03
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-ATC |
D07AC05
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
WHO-VATC |
QS01CA04
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB08971
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
4463
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB07717MIG
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
D005448
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
FLUOCORTOLONE
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
1206
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
DTXSID00861835
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
C80819
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
65VXC1MH0J
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
1904
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
100000080734
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
m5454
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | Merck Index | ||
|
205-811-5
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
9053
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
CHEMBL251634
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
152-97-6
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)